Private company

Enavate Sciences GP, LLC

American company, incorporated in Delaware. Summary from the record

Last updated Oct 21, 2026.

Overview

HeadquartersDE¹

See how the biggest companies compare on our leaderboards

Corporate structure

Enavate Sciences GP, LLC sits at the top of its group. 5 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Enavate Sciences GP, LLC DE
- Camp4 Therapeutics Corp Stake · Watertown, Massachusetts
- Immunome Inc. Stake · Bothell, Washington
- Sionna Therapeutics, Inc. Stake · Waltham, Massachusetts
- Zenas BioPharma, Inc. Stake · Waltham, Massachusetts

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (4 companies). Each entity in the chart links to its source.

Filings

8 filings to the SEC since October 2021: 8 other. The latest 8:

Aug 31, 2026N-PX EDGAR
Aug 14, 202613F-HR EDGAR
May 15, 202613F-HR EDGAR
Feb 17, 202613F-HR EDGAR
Nov 14, 202513F-HR EDGAR
Aug 14, 202513F-HR EDGAR
May 15, 202513F-HR EDGAR
Feb 14, 202513F-HR EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

Enavate Sciences GP, LLC has told the SEC it owns more than 5% of 4 companies, latest first (Schedules 13D and 13G).

Zenas BioPharma, Inc.SCHEDULE 13D/A Sep 23, 2024 to Aug 19, 2026²
Camp4 Therapeutics CorpSCHEDULE 13D/A Oct 22, 2024 to Mar 11, 2026³
Immunome Inc.SCHEDULE 13D/A Dec 22, 2025⁴
Sionna Therapeutics, Inc.SCHEDULE 13D Feb 18, 2025⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREnavate Sciences GP, LLC filings on SEC EDGAR
2
SEC EDGAREnavate Sciences GP, LLC SCHEDULE 13D/A on Zenas BioPharma, Inc.
3
SEC EDGAREnavate Sciences GP, LLC SCHEDULE 13D/A on Camp4 Therapeutics Corp
4
SEC EDGAREnavate Sciences GP, LLC SCHEDULE 13D/A on Immunome Inc.
5
SEC EDGAREnavate Sciences GP, LLC SCHEDULE 13D on Sionna Therapeutics, Inc.